IIM
SLS icon

INTECH Investment Management’s SELLAS Life Sciences SLS Stock Holding History

INTECH Investment Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Sell
32,182
-19,073
-37% -$132K ﹤0.01% 1369
2026
Q1 		$217K Buy
51,255
+10,983
+27% +$49.1K ﹤0.01% 1719
2025
Q4 		$152K Sell
40,272
-6,081
-13% -$11.8K ﹤0.01% 2066
2025
Q3 		$74.6K Buy
46,353
+136
+0.3% +$242 ﹤0.01% 2323
2025
Q2 		$101K Buy
+46,217
New +$70.9K ﹤0.01% 2291

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

INTECH Investment Management's SLS Position: Q2 2026 in Review

INTECH Investment Management reduced its SELLAS Life Sciences (SLS) stake by 37% in Q2 2026, selling an estimated $132K and leaving 32,182 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1369.

INTECH Investment Management first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • INTECH Investment Management held 32,182 shares of SELLAS Life Sciences worth $475K as of Q2 2026.
  • INTECH Investment Management sold 19,073 SELLAS Life Sciences shares in Q2 2026, an estimated $132K.
  • SELLAS Life Sciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1369 holding.
  • INTECH Investment Management first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.